{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:08:35Z","timestamp":1792728515792,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.anl.2022.11.004","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T07:38:04Z","timestamp":1671089884000},"page":"479-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Eosinophilic otitis media; state-of-the-art diagnosis and treatment"],"prefix":"10.1016","volume":"50","author":[{"given":"Yukiko","family":"Iino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2022.11.004_bib0001","unstructured":"Tomioka S, Kobayashi T, Takasaka T. Intractable otitis media in patients with bronchial asthma (eosinophilic otitis media) . In: Sanna M, ed. Cholesteatoma and Mastoid Surgery. Rome: CIC Edizioni Internazionali, 997: 851-3."},{"key":"10.1016\/j.anl.2022.11.004_bib0002","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.anl.2010.11.016","article-title":"Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease","volume":"38","author":"Iino","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0003","first-page":"112","article-title":"Epidemiologic Surveillance of \u201ceosinophilic otitis media\u201d in Japan","volume":"14","author":"Suzuki","year":"2004","journal-title":"Otol Jpn"},{"key":"10.1016\/j.anl.2022.11.004_bib0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.anl.2020.05.014","article-title":"Periostin in middle ear mucosa according to eosinophilic otitis media severity: middle ear pathology-based treatment","volume":"47","author":"Esu","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0005","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/00016489.2021.1901985","article-title":"Diagnosis and management of eosinophilic otitis media: a systematic review","volume":"141","author":"Chen","year":"2021","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1016\/j.anl.2022.11.004_bib0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.anl.2014.08.003","article-title":"Risk factors associated with severity of eosinophilic otitis media","volume":"41","author":"Kanazawa","year":"2014","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0007","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.anl.2022.11.004_bib0008","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11882-008-0096-5","article-title":"eosinophilic otitis media: A new middle ear disease","volume":"8","author":"Iino","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anl.2022.11.004_bib0009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.anl.2020.08.001","article-title":"Risk factors for bacterial infection to cause sensorineural hearing loss in eosinophilic otitis media","volume":"48","author":"Masuda","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000091215","article-title":"Intractable otitis media with eosinophils: importance of diagnosis and validity of treatment for hearing preservation","volume":"68","author":"Nakagawa","year":"2006","journal-title":"ORL J Otorhinolaryngol related Spec"},{"key":"10.1016\/j.anl.2022.11.004_bib0011","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/MAO.0b013e318185fb0d","article-title":"Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma","volume":"29","author":"Iino","year":"2008","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.11.004_bib0012","first-page":"838","article-title":"The role of periostin in eosinophilic otitis media","volume":"132","author":"Nishizawa","year":"2012","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2022.11.004_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0385-8146(01)00124-9","article-title":"Clinical characteristics of so-called eosinophilic otitis media","volume":"29","author":"Nagamine","year":"2002","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0014","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.anl.2018.07.011","article-title":"Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media","volume":"46","author":"Iino","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/00016489.2017.1385845","article-title":"Eosinophilic otitis media diagnosis using flow cytometric immunophenotyping","volume":"138","author":"Saliba","year":"2018","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2022.11.004_bib0016","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N Engl J. Med"},{"key":"10.1016\/j.anl.2022.11.004_bib0017","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaci.2015.04.041","article-title":"Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes","volume":"137","author":"Ueki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anl.2022.11.004_bib0018","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.alit.2017.11.007","article-title":"ETosis-derived DNA trap production in middle ear effusion is a common feature of eosinophilic otitis media","volume":"67","author":"Ohta","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2022.11.004_bib0019","first-page":"472","article-title":"Association between eosinophilic sinusitis and eosinophilic otitis media. Oto-Rhino-Laryngol","volume":"46","author":"Haruna","year":"2003","journal-title":"Tokyo"},{"key":"10.1016\/j.anl.2022.11.004_bib0020","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/all.13370","article-title":"Comorbid \u201ctreatable traits\u201d in difficult asthma: Current evidence and clinical evaluation","volume":"73","author":"Tay","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.anl.2022.11.004_bib0021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.alit.2019.02.004","article-title":"Severe asthma in Japan","volume":"68","author":"Nagase","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2022.11.004_bib0022","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1097\/MAO.0000000000002295","article-title":"Differentiation between eosinophilic otitis media and otitis media associated with eosinophilic granulomatosis with polyangiitis","volume":"40","author":"Fukuda","year":"2019","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.11.004_bib0023","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1097\/MAO.0000000000003431","article-title":"The quantification of extracellular trap cell death-derived products as diagnostic biomarkers for otitis media with antineutrophil cytoplastmic antibody-associated vasculitis and eosinophilic otitis media","volume":"43","author":"Morita","year":"2022","journal-title":"Otol Neuotol"},{"key":"10.1016\/j.anl.2022.11.004_bib0024","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.anorl.2018.03.009","article-title":"Hypereosinophilic syndrome presenting with bilateral ear fullness","volume":"136","author":"Jung","year":"2019","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.anl.2022.11.004_bib0025","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1097\/MAO.0000000000001912","article-title":"Proposal of a treatment strategy for eosinophilic otitis media based on middle ear condition","volume":"39","author":"Esu","year":"2018","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.11.004_bib0026","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/all.13814","article-title":"Periostin: An emerging biomarker for allergic diseases","volume":"74","author":"Izuhara","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.anl.2022.11.004_bib0027","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/MAO.0b013e318263d5b8","article-title":"Clinical efficacy of anti-IgE therapy for eosinophilic otitis media","volume":"33","author":"Iino","year":"2012","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.11.004_bib0028","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.anl.2020.09.005","article-title":"Effectiveness of myringoplasty in patients with eosinophilic otitis media","volume":"48","author":"Esu","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0029","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/jcm11040926","article-title":"Efficacy of biologics on refractory eosinophilic otitis media associated with bronchial asthma or severe uncontrolled CRSwNP","volume":"11","author":"De Corso","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.anl.2022.11.004_bib0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.anl.2020.09.001","article-title":"Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma","volume":"48","author":"Iino","year":"2021","journal-title":"Auris Nasus Larynx"},{"issue":"Suppl","key":"10.1016\/j.anl.2022.11.004_bib0031","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","article-title":"Staging for rhinosinusitis","volume":"117","author":"Lund","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2022.11.004_bib0032","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.anl.2006.05.007","article-title":"Successful treatment of eosinophilic otitis media using ramatroban: report of two cases","volume":"33","author":"Wada","year":"2006","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0033","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4172\/2155-9899.1000538","article-title":"Tretament of eosinophilic otitis media","volume":"9","author":"Matsubara","year":"2018","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.anl.2022.11.004_bib0034","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/lary.26303","article-title":"Treatment of eosinophilic otitis media with pegylated interferon-a 2a and 2b","volume":"127","author":"Neff","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2022.11.004_bib0035","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.5415\/apallergy.2018.8.e5","article-title":"Optimal control of asthma improved eosinophilic otitis media","volume":"8","author":"Seo","year":"2018","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.anl.2022.11.004_bib0036","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1081-1206(10)60967-2","article-title":"Effectiveness of instillation of triamcinolone acetonide into middle ear for eosinophilic otitis media associated with bronchial asthma","volume":"97","author":"Iino","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anl.2022.11.004_bib0037","series-title":"Recent advances in otitis media","first-page":"403","article-title":"The effect of topical administration of heparin to the eosinophilic otitis media","author":"Matsubara","year":"2001"},{"key":"10.1016\/j.anl.2022.11.004_bib0038","first-page":"29","article-title":"Clinical course of patients with eosinophilic otitis media treated by intensive care","volume":"30","author":"Kikuchi","year":"2020","journal-title":"Otol Jpn"},{"key":"10.1016\/j.anl.2022.11.004_bib0039","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2332\/allergolint.10-RAI-0223","article-title":"Role of IgE in eosinophilic otitis media","volume":"59","author":"Iino","year":"2010","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2022.11.004_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anai.2014.04.021","article-title":"Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media","volume":"113","author":"Kanazawa","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anl.2022.11.004_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/340525","article-title":"A case of severe asthma whit eosinophilic otitis media successfully treated with anti-IgE monoclonal antibody omalizumab","author":"Okude","year":"2012","journal-title":"Case Reports in Pulmonology"},{"key":"10.1016\/j.anl.2022.11.004_bib0042","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5152\/iao.2018.4517","article-title":"Eosinophilic otitis media treated with anti-IgE monoclonal antibodies and a bone conduction implant","volume":"14","author":"Han","year":"2018","journal-title":"J Int Adv Otol"},{"key":"10.1016\/j.anl.2022.11.004_bib0043","article-title":"Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics","author":"Bartier","year":"2022","journal-title":"J Asthma"},{"key":"10.1016\/j.anl.2022.11.004_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102032","article-title":"Characteristics of patients with severe asthma who experienced treatment failure with omalizumab","volume":"68","author":"Akaba","year":"2021","journal-title":"Pulmonary Pharmacology Therapeutics"},{"key":"10.1016\/j.anl.2022.11.004_bib0045","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1365-2222.2001.01134.x","article-title":"Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma","volume":"31","author":"Iino","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anl.2022.11.004_bib0046","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/0036554021000028117","article-title":"IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion","volume":"123","author":"Nonaka","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2022.11.004_bib0047","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.anl.2018.05.007","article-title":"Successful treatment of eosinophilic otitis media associated with bronchial asthma with an anti-IL5 monoclonal antibody, mepolizumab","volume":"46","author":"Suzaki","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0048","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X21991449","article-title":"Role of interleukin 5 inhibition in the treatment of eosinophilic otitis media","volume":"5","author":"Breslin","year":"2021","journal-title":"OTO-open"},{"key":"10.1016\/j.anl.2022.11.004_bib0049","article-title":"dupilumab remarkably improved eustachian tub obstruction: a case of mepolizumab-resistant eosinophilic otitis media","volume":"33","author":"Takesita","year":"2023","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.anl.2022.11.004_bib0050","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2013.05.020","article-title":"Effect of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia","volume":"132","author":"Laviolette","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anl.2022.11.004_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmcr.2020.101135","article-title":"Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using an anti-IL-5 receptor monoclonal antibody benralizumab: A case report","volume":"30","author":"Kagoshima","year":"2020","journal-title":"Respiratory Med Case Reports"},{"key":"10.1016\/j.anl.2022.11.004_bib0052","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1097\/MAO.0000000000002493","article-title":"Use of IL-5 inhibitor benralizumab as a novel therapy for eosinophilic otitis meia: clinical capsule and review of literature","volume":"41","author":"Chow","year":"2020","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2022.11.004_bib0053","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.3390\/ijms222011209","article-title":"IL-13 may play an important role in developing eosinophilic chronic rhinosinusitis and eosinophilic otitis media","volume":"22","author":"Shimizu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anl.2022.11.004_bib0054","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/lary.29730","article-title":"Complete remission of severe eosinophilic otitis media with dupilumab: a case report","volume":"131","author":"van der Lans","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2022.11.004_bib0055","unstructured":"https:\/\/www.jsaweb.jp\/uploads\/files\/20200621ST.pdf"},{"key":"10.1016\/j.anl.2022.11.004_bib0056","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.alit.2015.03.007","article-title":"Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophililc otitis media","volume":"64","author":"Uchimizu","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2022.11.004_bib0057","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.alit.2021.02.002","article-title":"Cycling therapy with benraliumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media","volume":"70","author":"Hamada","year":"2021","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2022.11.004_bib0058","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/biom12040522","article-title":"Sequential biotherapy targeting IL5 and IL4\/13 in patients with eosinophilic asthma with sinusitis and otitis media","volume":"12","author":"Chikumoto","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.anl.2022.11.004_bib0059","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archotol.132.10.1109","article-title":"Eustachian tube function in patients with eosinophilic otitis media","volume":"132","author":"Iino","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2022.11.004_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.xocr.2021.100381","article-title":"A case of eosinophilic otitis media successfully treated by tympanoplasty with use of dupilumab","volume":"21","author":"Kikuchi","year":"2021","journal-title":"Otolaryngology Case reports"},{"key":"10.1016\/j.anl.2022.11.004_bib0061","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00405-005-1006-2","article-title":"Cochlear implantation in a patients with eosinophilic otitis media","volume":"263","author":"Iwasaki","year":"2006","journal-title":"Eur Arch Otorhinolarungol"},{"key":"10.1016\/j.anl.2022.11.004_bib0062","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.anl.2010.01.009","article-title":"Cochlear implantation in patients with chronic otitis media","volume":"37","author":"Kojima","year":"2010","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2022.11.004_bib0063","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00405-016-4091-5","article-title":"cochlear implantation in deaf patients with eosinophilic otitis media using subtotal petrosectomy and mastoid obliteration","volume":"274","author":"Sugimoto","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2022.11.004_bib0064","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1056\/NEJMicm1510852","article-title":"Eosinophilic otitis media","volume":"376","author":"Hugo","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2022.11.004_bib0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12105-018-0952-0","article-title":"Idiopathic, infectious and reactive lesions of the ear and temporal bone","volume":"12","author":"Magliocca","year":"2018","journal-title":"Head and Neck Pathology"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814622002255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814622002255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:39:45Z","timestamp":1759952385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814622002255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0385814622002255"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2022.11.004","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilic otitis media; state-of-the-art diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}